With the announcement of a $500,000 donation to the UCSC Genomics Institute in support of the UCSC Paleogenomics Lab, Colossal continues to expand its ancient DNA academic collaborations.

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces that it has filed a patent application to protect the recently developed Optimer binder sequences for novel applications.

Thermo Fisher Scientific, Inc. is debuting its recently launched innovative products, hosting educational presentations and showcasing live lab demos for customers working in laboratory technology, analysis, biotechnology, and environmental quality.

Collaboration leverages cutting-edge digital platform to streamline development and manufacturing activities and speed patient access to life-changing treatments.

With its Vivalytic analysis platform, Bosch has set itself the goal of making fast and highly precise diagnostics accessible at the point of care. To achieve this, Bosch has now agreed on a strategic partnership with Randox Laboratories Ltd.

AMSBIO reports that its extensive range of FDA tissue microarrays reliably enhances tissue cross-reactivity (TCR) and other target validation studies.

Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024.

Innovative Hi-C-like technique shows enhanced sensitivity for detecting structural variants and chromatin topology features in cancer.

Enhanced performance and 33% energy savings support quality and sustainability goals in the laboratory.

Collaboration aims to grow clinical evidence supporting the use of bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types.